Literature DB >> 9544889

Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.

M R DeBaun1, M A Tucker.   

Abstract

To determine the incidence and relative risk (RR) of cancer in children with Beckwith-Wiedemann syndrome (BWS), children with BWS were followed up from birth until death, diagnosis of cancer, fourth birthday, or last day of follow-up. A total of 183 children with BWS were followed up for 482 person-years. The end points were incidence of cancer, RR of cancer, and RR associated with specific BWS phenotypic features. Thirteen children were identified with cancers before the fourth year of life in comparison with fewer than one cancer expected in this group on the basis of general population rates over the same period. The average annual incidence of cancer in the first 4 years of life was 0.027 cancer per person-year. The RR of Wilms tumor (RR = 816; 95% confidence interval [CI], 359-1156), neuroblastoma (RR = 197; 95% CI, 22-711), and hepatoblastoma (RR = 2280; 95% CI, 928-11,656) were statistically significant. Asymmetry of the limbs (hemihypertrophy) was the only clinical feature associated with an increased RR of cancer (RR = 4.6; 95% CI, 1.5-14.2). Given the high incidence of cancer in infancy and early childhood of patients with BWS, a prospective study is warranted to address the utility of screening for cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9544889     DOI: 10.1016/s0022-3476(98)70008-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  88 in total

1.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.

Authors:  Adam C Smith; Masako Suzuki; Reid Thompson; Sanaa Choufani; Michael J Higgins; Idy W Chiu; Jeremy A Squire; John M Greally; Rosanna Weksberg
Journal:  Genomics       Date:  2011-11-03       Impact factor: 5.736

3.  Beckwith-Wiedemann syndrome and IVF: a case-control study.

Authors:  Jane Halliday; Kay Oke; Sue Breheny; Elizabeth Algar; David J Amor
Journal:  Am J Hum Genet       Date:  2004-09       Impact factor: 11.025

4.  Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Licia Peruzzi; Nicoletta Chiesa; Agostina De Crescenzo; Silvia Russo; Daniela Melis; Luigi Tarani; Giuseppina Baldassarre; Lidia Larizza; Andrea Riccio; Margherita Silengo; Giovanni Battista Ferrero
Journal:  Pediatr Nephrol       Date:  2011-10-21       Impact factor: 3.714

Review 5.  [Current status of diagnosis and treatment of hepatoblastoma].

Authors:  Purificación García-Miguel; Manuel López Santamaría
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

6.  Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings.

Authors:  Matteo Baldisserotto; Adriana Barcellos Peletti; Manoel Angelo de Araújo; Ana Paula Cardoso Pertence; Marcelo Dourado Dora; Elines Oliva Maciel; Ana Maria Gaiger
Journal:  Pediatr Radiol       Date:  2005-06-28

7.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

8.  The extent of DNA methylation anticipation due to a genetic defect in ICR1 in Beckwith-Wiedemann syndrome.

Authors:  Feifei Sun; Ken Higashimoto; Atsuko Awaji; Kenji Ohishi; Naoto Nishizaki; Yuka Tanoue; Saori Aoki; Hidetaka Watanabe; Hitomi Yatsuki; Hidenobu Soejima
Journal:  J Hum Genet       Date:  2019-06-24       Impact factor: 3.172

9.  Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  Pediatr Blood Cancer       Date:  2018-09-30       Impact factor: 3.167

10.  Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Authors:  Rajkumar Venkatramani; Logan G Spector; Michael Georgieff; Gail Tomlinson; Mark Krailo; Marcio Malogolowkin; Wendy Kohlmann; Karen Curtin; Rachel K Fonstad; Joshua D Schiffman
Journal:  Am J Med Genet A       Date:  2014-06-16       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.